Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Popoli

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Neurobiology of Disease|August 28, 2007
Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease miceM R Domenici, M L Scattoni, A Martire, et al.
Purinergic Signalling|April 12, 2008
Adenosine A(2A) receptors modulate BDNF both in normal conditions and in experimental models of Huntington's diseaseR L Potenza, M T Tebano, A Martire, et al.
Neurology|December 10, 2003
Modulation of glutamate release and excitotoxicity by adenosine A2A receptorsP Popoli, C Frank, M T Tebano, et al.
Current Pharmaceutical Design|June 10, 2008
An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptorsS Ferré, C Quiroz, A S Woods, et al.
Brain Research Bulletin|January 1, 1994
Behavioral and electrophysiological correlates of the quinolinic acid rat model of Huntington's disease in ratsP Popoli, A Pèzzola, M R Domenici, et al.
Journal of Neurochemistry|November 17, 2007
Adenosine A(2A) receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampusM T Tebano, A Martire, R L Potenza, et al.
Journal of Neurochemistry|November 8, 2005
Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effectsM T Tebano, A Martire, N Rebola, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 18, 2007
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activationR M Moresco, T Lavazza, S Belloli, et al.
Neuropharmacology|August 10, 2006
The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatumA Pintor, M T Tebano, A Martire, et al.
Neurology|December 10, 2003
Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's diseaseK Fuxe, L F Agnati, K Jacobsen, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Neurobiology of Disease|August 28, 2007
Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease miceM R Domenici, M L Scattoni, A Martire, et al.
Purinergic Signalling|April 12, 2008
Adenosine A(2A) receptors modulate BDNF both in normal conditions and in experimental models of Huntington's diseaseR L Potenza, M T Tebano, A Martire, et al.
Neurology|December 10, 2003
Modulation of glutamate release and excitotoxicity by adenosine A2A receptorsP Popoli, C Frank, M T Tebano, et al.
Current Pharmaceutical Design|June 10, 2008
An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptorsS Ferré, C Quiroz, A S Woods, et al.
Brain Research Bulletin|January 1, 1994
Behavioral and electrophysiological correlates of the quinolinic acid rat model of Huntington's disease in ratsP Popoli, A Pèzzola, M R Domenici, et al.
Journal of Neurochemistry|November 17, 2007
Adenosine A(2A) receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampusM T Tebano, A Martire, R L Potenza, et al.
Journal of Neurochemistry|November 8, 2005
Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effectsM T Tebano, A Martire, N Rebola, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 18, 2007
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activationR M Moresco, T Lavazza, S Belloli, et al.
Neuropharmacology|August 10, 2006
The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatumA Pintor, M T Tebano, A Martire, et al.
Neurology|December 10, 2003
Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's diseaseK Fuxe, L F Agnati, K Jacobsen, et al.
Pageof 8